News – Optio Biopharma Solutions, LLC

Surmounting market challenges and exceeding client objectives since 2007.

Office (650) 308 4999

HomeNews

Eric Miller appointed as Executive Director of global rare disease advocacy group – March 2020

March 9, 2020

Optio attends CHDI – February 2020, Palm Springs, USA

February 27, 2020

Optio attends the Huntington Study Group annual meeting – November 2019, Sacramento, CA

November 27, 2019

JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activities

January 15, 2019

The Huntington’s market heats up – observations as Optio attends the November 2018 HSG congress.

November 11, 2018

Optio attends Huntington’s Disease Society of America 33rd annual convention – Los Angeles, June 2018

June 6, 2018

Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018

January 15, 2018

Optio conducts social worker and caregiver focus group research at a neurological rare disease meeting – Chicago, IL.

June 21, 2017

Optio conducts business development interviews for a rare disease product valuation in conjunction with the 35th Annual J.P. Morgan Healthcare Conference.

January 9, 2017

Optio Biopharma Solutions attends the 23rd Annual Huntington’s Study Group Meeting and 10th Annual Clinical Research Symposium in Nashville, TN.

November 2, 2016

Tweets by OptioBiopharma

All new engagements start with a meeting.